Editorial: Highlights in Hypertension: 2021

by Guido Iaccarino
Published 2022-06-01

Editorial: Insights in hypertension: 2022

by Guido Iaccarino
Published 2023-09-01

Editorial: Case reports in hypertension: 2022

by Guido Iaccarino
Published 2023-05-01

Physical Exercise: A Novel Tool to Protect Mitochondrial Health

by Daniela Sorriento, Daniela Sorriento, Eugenio Di Vaia, Guido Iaccarino, Guido Iaccarino
Published 2021-04-01

Inflammation and Cardiovascular Diseases: The Most Recent Findings

by Daniela Sorriento, Guido Iaccarino
Published 2019-08-01

Gene–environment interactions and vitamin D effects on cardiovascular risk

by Guido Iaccarino, Bruno Trimarco
Published 2019-08-01

The Cardiovascular Phenotype in Fabry Disease: New Findings in the Research Field

by Daniela Sorriento, Guido Iaccarino
Published 2021-01-01

Commentary: Studies in Zebrafish Demonstrate That CNNM2 and NT5C2 Are Most Likely the Causal Genes at the Blood Pressure-Associated Locus on Human Chromosome 10q24.32

by Daniela Sorriento, Guido Iaccarino
Published 2020-10-01

The Future Evolution of the Mortality Acceleration Due to the COVID-19: The Charlson Comorbidity Index in Stochastic Setting

by Maria Carannante, Valeria D'Amato, Guido Iaccarino
Published 2022-07-01

Impaired mitochondrial calcium uptake caused by tacrolimus underlies beta-cell failure

by Angela Lombardi, Bruno Trimarco, Guido Iaccarino, Gaetano Santulli
Published 2017-11-01

The Antioxidant Therapy: New Insights in the Treatment of Hypertension

by Daniela Sorriento, Nicola De Luca, Bruno Trimarco, Guido Iaccarino
Published 2018-03-01

GRKs and β-Arrestins: “Gatekeepers” of Mitochondrial Function in the Failing Heart

by Daniela Sorriento, Jessica Gambardella, Antonella Fiordelisi, Guido Iaccarino, Maddalena Illario
Published 2019-02-01

“Freeze, don’t move”: how to arrest a suspect in heart failure. A review on available GRK2 inhibitors.

by Daniela Sorriento, Michele Ciccarelli, Ersilia Cipolletta, Bruno Trimarco, Guido Iaccarino
Published 2016-12-01

NFkappaB is a Key Player in the Crosstalk between Inflammation and Cardiovascular Diseases

by Antonella Fiordelisi, Guido Iaccarino, Carmine Morisco, Enrico Coscioni, Daniela Sorriento
Published 2019-03-01

The impact of β 2 adrenergic receptor polymorphisms on the outcomes in cardiovascular diseases

by Ersilia Cipolletta, Annalisa Carillo, Roberto Annunziata, Bruno Trimarco, Antonietta Franco, Guido Iaccarino
Published 2014-12-01

Diazoxide Improves Mitochondrial Connexin 43 Expression in a Mouse Model of Doxorubicin-Induced Cardiotoxicity

by Michela Pecoraro, Michele Ciccarelli, Antonella Fiordelisi, Guido Iaccarino, Aldo Pinto, Ada Popolo
Published 2018-03-01

Novel Therapeutic Targets in Metabolic Disorders: From the Bench to the Bedside

by Maddalena Illario, Carolina Di Somma, Guido Iaccarino, Pietro Campiglia, Uma Sankar, Nunzia Montuori
Published 2014-01-01

Active and Healthy Ageing and Independent Living

by Maddalena Illario, Miriam Vollenbroek-Hutten, David William Molloy, Enrica Menditto, Guido Iaccarino, Patrik Eklund
Published 2015-01-01

The Amino-Terminal Domain of GRK5 Inhibits Cardiac Hypertrophy through the Regulation of Calcium-Calmodulin Dependent Transcription Factors

by Daniela Sorriento, Gaetano Santulli, Michele Ciccarelli, Angela Serena Maione, Maddalena Illario, Bruno Trimarco, Guido Iaccarino
Published 2018-03-01

Cardiotoxic Effects of Short-Term Doxorubicin Administration: Involvement of Connexin 43 in Calcium Impairment

by Michela Pecoraro, Antonio Rodríguez-Sinovas, Stefania Marzocco, Michele Ciccarelli, Guido Iaccarino, Aldo Pinto, Ada Popolo
Published 2017-10-01